HIVMA and IDSA are working with the National Coalition of STD Directors (NCSD) and Treatment Action Group (TAG) to address supply and cost issues affecting our response to the growing STI epidemic. ID, HIV and primary care providers, health department STD programs, and consumers are encouraged to use this new tool to help us track any issues related to accessing BPG and other STI medications.

The U.S. Preventive Services Task Force Draft Recommendation of an “A” grade for prevention of HIV infection with Pre-Exposure Prophylaxis released today holds the potential to facilitate access to a proven and valuable intervention for people who are exposed to higher risks of HIV infection. While access to antiretroviral medication used to prevent HIV infection – PrEP -- is safe and effective, just a small percentage of those who would benefit from PrEP currently receive it.

Data showing a tripling of hepatitis C cases across America during the last decade highlight urgent and multi-faceted public health needs for expanded access to prevention, screening and treatment in addition to integrated health services that provide care for substance use disorders and associated infectious diseases.